HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir.

AuthorsC Bernardeschi, L Valeyrie-Allanore, N Ortonne, L Gressier, N Wallet-Faber, P-H Bernard, C Hezode, J-C Duclos-Vallée, D Samuel, V Mallet, S Pol, B Milpied, N Dupin
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 30 Issue 1 Pg. 143-6 (Jan 2016) ISSN: 1468-3083 [Electronic] England
PMID25187266 (Publication Type: Letter, Multicenter Study)
Chemical References
  • Antiviral Agents
  • Oligopeptides
  • Ribavirin
  • telaprevir
  • Interferons
Topics
  • Aged
  • Antiviral Agents (adverse effects, therapeutic use)
  • Biopsy
  • Drug Eruptions (diagnosis)
  • Female
  • Hepatitis C (drug therapy)
  • Humans
  • Interferons (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Oligopeptides (adverse effects, therapeutic use)
  • Prospective Studies
  • Ribavirin (adverse effects, therapeutic use)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: